Back to Search
Start Over
Effect of ruthenium(II) complexes on MDA-MB-231 cells and lifespan/tumor growth in gld-1mutant, Daf-16 TF and stress productive genes: A perspective study.
- Source :
-
Journal of inorganic biochemistry [J Inorg Biochem] 2024 Aug; Vol. 257, pp. 112580. Date of Electronic Publication: 2024 Apr 28. - Publication Year :
- 2024
-
Abstract
- Pincer type coumarin based N-substituted semicarbazone ligands HL <superscript>1-4</superscript> and their corresponding ruthenium(II) complexes (1-4) were synthesized, analyzed and confirmed by various spectro analytical techniques. The molecular structure of the ligand HL <superscript>3</superscript> and complex 3 was confirmed by single crystal X-ray diffraction analysis. The stoichiometry of complexes 1, 2 and 4 was confirmed by high resolution mass spectroscopy (HRMS). The binding affinity of the compounds with CT-DNA (Calf Thymus DNA) and BSA (Bovine Serum Albumin) was established by absorption and emission titration methods. The results of In vitro cytotoxicity showed the significant cytotoxic potential of the complexes against MDA-MB-231 cells (TNBC- Triple-negative breast cancer). Among the complexes, 1 and 4 have shown appreciable results. Further, antimigratory activity against the MDA-MB-231 cells was studied for the complexes 1 and 4. The percentage cell cycle arrest, apoptosis and necrosis were explored by flow cytometry. The in vivo anti-tumor activity of the complexes 1 and 4 using C. elegans as model organism was established by using the tumoral C. elegans strain JK1466 (gld-1(q485)), which bears a mutation in the gld-1 tumor suppressor gene. We have determined the effect of our complexes on tumor gonad reduction and found to be non toxic to the JK1466 worms and they have prolonged their mean lifespan with potential antioxidant ability by overcoming stress responses. Overall, our study reported herein demonstrated that the complexes 1 and 4 could be established as potential metallo-drugs substantiating further exploration.<br />Competing Interests: Declaration of competing interest We authors declare that we are having any conflicts of interest in publishing this current manuscript in Journal of Inorganic Biochemistry as full research article.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Animals
Cell Line, Tumor
Apoptosis drug effects
Caenorhabditis elegans Proteins metabolism
Caenorhabditis elegans Proteins genetics
Forkhead Transcription Factors metabolism
Forkhead Transcription Factors genetics
Longevity drug effects
Female
MDA-MB-231 Cells
Coordination Complexes pharmacology
Coordination Complexes chemical synthesis
Coordination Complexes chemistry
Ruthenium chemistry
Ruthenium pharmacology
Caenorhabditis elegans drug effects
Caenorhabditis elegans genetics
Caenorhabditis elegans metabolism
Antineoplastic Agents pharmacology
Antineoplastic Agents chemistry
Antineoplastic Agents chemical synthesis
Subjects
Details
- Language :
- English
- ISSN :
- 1873-3344
- Volume :
- 257
- Database :
- MEDLINE
- Journal :
- Journal of inorganic biochemistry
- Publication Type :
- Academic Journal
- Accession number :
- 38701694
- Full Text :
- https://doi.org/10.1016/j.jinorgbio.2024.112580